Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
FDA Removes Clinical Hold On Biomea Fusion's Early-Stage Trials For Potential Diabetes Candidate
September 27, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BMEA
FDA Approves Regeneron/Sanofi's Blockbuster Dupixent For Smoker's Lung Disease
September 27, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
REGN
SNY
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp.’s (NASDAQ: TNXP) Receives New US Patent for Subcutaneous Administration of Zembrace(R) SymTouch(R) to Treat Migraines
September 27, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
TNXP
Regeneron And Sanofi Snag Their $6 Billion-Potential COPD Approval For Dupixent
September 27, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
REGN
SNY
VRNA
Mercedes-Benz, Toyota, Mazda Issue Massive Recalls Over Software Defects: NHTSA Warns Of Fire, Brake And Airbag Risks
September 27, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
MBGAF
MBGYY
MZDAF
TM
Creative Biolabs: Lock and Load with Next-Gen mRNA Tech
September 24, 2024
Via
Get News
Topics
Death
Exposures
COVID-19
Death
Product Safety
Schizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb' Cobenfy As New Class Of Treatment In More Than 3 Decades
September 27, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BMY
PRTC
Bristol-Myers Squibb's Novel Schizophrenia Drug Wins FDA Approval; BMY Stock Signals Breakout
September 26, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
BMY
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) to Participate at the Cell & Gene Meeting on the Mesa
September 26, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
LGVN
IBN Coverage: Clene (NASDAQ: CLNN) to Discuss CNM-Au8(R) Data FDA Leadership
September 26, 2024
Via
NewMediaWire
Exposures
Product Safety
Tickers
CLNN
AstraZeneca's Top-Selling Cancer Drug Tagrisso Receives FDA Green Light For Another Lung Cancer Indication
September 26, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
AZN
DGE’s 5th Human Factors Engineering and Usability Studies Congress Discusses Ways of Improving User Experience
September 26, 2024
Via
Investor Brand Network
Exposures
Product Safety
GM Recalls Over 18K Vans In US Over Brake Fluid Leak Concerns
September 26, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
GM
Entrepreneur Javid Javdani Builds Community Through Balboa Market
September 26, 2024
Via
Zexprwire
Topics
Product Recall
Exposures
Legal
Product Safety
Stellantis Recalls Nearly 16K Fiat 124 Spider Roadster Vehicles In The US Over Improper Airbag Deployment Concerns
September 26, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
STLA
FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
September 25, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BGNE
BMY
MRK
Marina Medical Instruments Partners with FAGA to Address Gaps in Surgical Devices
September 25, 2024
Via
Prodigy
Exposures
Product Safety
Bristol Myers-2seventy Bio Halt Phase 3 Trial For Abecma In Newly Diagnosed Myeloma Patients, Speeds Path To Profitability
September 25, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BMY
NVO
TSVT
Emergent BioSolutions Confirms Orders Worth $400M Related To Smallpox, Mpox Vaccines
September 25, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
EBS
Eli Lilly Touts Results Of EU-Approved Dermatitis Treatment, Shows Sustained Disease Control For Up To Three Years
September 25, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
LLY
MRK
Florida Cannabis Ballot: NFL's Ricky Williams Backs Legalization, New Ad 'Hypocrisy Of Alcohol Vs. Marijuana'
September 24, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Product Safety
Clene Inc. (NASDAQ: CLNN) to Discuss Lead Candidate CNM-Au8(R) Biomarker, Clinical Data for ALS with Food and Drug Administration Leadership
September 24, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CLNN
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse
September 24, 2024
Via
FinancialNewsMedia
Exposures
Product Safety
Tickers
AMRX
LLY
NTRB
NTRBW
RHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU announced
September 24, 2024
Via
PR Leap
Exposures
Product Safety
Graphic Cabin™ by Hatfield Creative: Your Local Partner for Custom Beverage Labels, Wall Decals, and Trade Show Displays
September 23, 2024
Via
Syndication Cloud
Exposures
Product Safety
Cybersecurity for Medical Devices: 4 Ways to Remain Compliant
September 23, 2024
Via
Syndication Cloud
Exposures
Product Safety
Gilead Sciences Recalls One Lot Of Its COVID-19 Treatment Due To Presence Of Glass Particles
September 23, 2024
Via
Benzinga
Topics
Product Recall
Exposures
COVID-19
Legal
Product Safety
Tickers
GILD
Biohaven Stock Spikes After Drug Candidate To Treat Rare Neurodegenerative Disease Shows Promise
September 23, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BHVN
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Participate in Global Conference with Three TNX-102 SL Data Presentations
September 23, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
TNXP
New Study Warns of High Dose "ADHD" Drugs Inducing Psychosis
September 23, 2024
Via
PRLog
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.